AbbVie Inc. (ABBV) Financials

ABBV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 ? ?
Dec. 31, 2025 134.0 billion 137.2 billion
Sept. 30, 2025 133.9 billion 136.5 billion
June 30, 2025 137.2 billion 137.3 billion

ABBV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 4.9 billion 157.0 million
Sept. 30, 2025 7.5 billion 209.0 million
June 30, 2025 4.9 billion 179.0 million

ABBV Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 ?
Dec. 31, 2025 1.8 billion
Sept. 30, 2025 188.0 million
June 30, 2025 941.0 million

ABBV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - -
Dec. 31, 2025 5.3 billion 59.6 billion 711.0 million
Sept. 30, 2025 5.7 billion 63.0 billion -
June 30, 2025 6.5 billion 63.0 billion -

ABBV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.8 billion
Dec. 31, 2025 1.8 billion
Sept. 30, 2025 1.8 billion
June 30, 2025 1.8 billion

ABBV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - - 3.6 billion -
Dec. 31, 2025 329.0 million 2.6 billion 3.9 billion -
Sept. 30, 2025 504.0 million 2.3 billion 3.6 billion -
June 30, 2025 269.0 million 2.1 billion 3.3 billion -

ABBV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 15.0 billion 2.5 billion
Dec. 31, 2025 16.6 billion 4.6 billion
Sept. 30, 2025 15.8 billion 5.3 billion
June 30, 2025 15.4 billion 4.3 billion

ABBV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ABBV

List: Contenders

Price: $217.07

52 week price:
171.00
244.81

Dividend Yield: 3.26%

5-year range yield:
3.00%
5.38%

Forward Dividend Yield: 3.19%

Payout Ratio: 207.36%

Payout Ratio Range:
-12509.09%
5836.11%

Dividend Per Share: 6.92 USD

Earnings Per Share: 2.06 USD

P/E Ratio: 101.05

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 6.2 million

Ebitda: 1.9 billion

Market Capitalization: 368.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 14

DGR3: 5.59%

DGR5: 7.25%

DGR10: 13.61%

Links: